• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD have to make a difficult choice about whether to continue or stop taking adhd medication and pregnancy uk medication during pregnancy and breast-feeding. There are few data regarding how exposure over the counter adhd medication uk time may affect the foetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to Safest Adhd Medication medication during pregnancy do not develop neurological disorders such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are required.

Risk/Benefit Analysis

Pregnant women who use ADHD medications need to balance the advantages of taking them against the potential risks to the fetus. Doctors don't have the data needed to make unequivocal recommendations but they can provide information about benefits and risks that can help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who took ADHD medications in early pregnancy did not have an increased risk of fetal heart malformations or major structural birth defects. Researchers conducted a large sample-based case control study to examine the prevalence of structural defects that were major in infants born to mothers who used stimulants during pregnancy. Clinical geneticists and pediatric cardiologists examined the cases to ensure correct case classification and to limit the chance of bias.

However, the study had its limitations. Most important, they were unable to distinguish the effects of the medication from the disorder that is underlying. This limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to medication use or the confounding effect of comorbidities. Additionally the researchers did not examine the long-term effects of offspring on their parents.

The study found that infants whose mother took ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU), compared to mothers who didn't take any medication during pregnancy, or had discontinued taking their medication prior to or during pregnancy. This increase was caused by central nervous system disorders. The higher risk of admission was not affected by the stimulant medication used during pregnancy.

Women who used stimulant ADHD medication during pregnancy also had an increased risk of having a caesarean section or having a baby with an low Apgar score (less than 7). These risks did not seem to be influenced by the type of medication that was used during pregnancy.

Researchers suggest that the small risks posed by the use of ADHD medications in early pregnancies may be offset by the more beneficial outcomes for both baby and mother of continued treatment for the woman’s disorder. Physicians should discuss the issue with their patients and, if they are able, assist them in developing strategies to improve their coping abilities that may minimize the effects of her disorder on her daily functioning and relationships.

Medication Interactions

As more women than ever are being diagnosed with best adhd medication for adults and being treated with medication, the issue of whether to keep or discontinue treatment during pregnancy is one that doctors are having to confront. These decisions are usually made without clear and reliable evidence. Instead, doctors have to weigh their own knowledge, the experience of other physicians and the research on the subject.

Particularly, the issue of possible risks to the baby can be a challenge. The research on this subject is based on observations rather than controlled studies, and the results are contradictory. The majority of studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that can lead to abortions or terminations of pregnancy. The study that is discussed in the journal club addresses these shortcomings by analyzing both information on deceased and live births.

Conclusion Some studies have revealed a positive correlation between ADHD medications and certain birth defects, other studies have not found a correlation. The majority of studies show that there is a neutral, or slight negative impact. In all cases it is imperative to conduct a thorough analysis of the benefits and risks must be performed.

It isn't easy, but not impossible, for women with ADHD to stop taking their medication. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of isolation. A loss of medication may also impact the ability to safely drive and perform work-related tasks, which are vital aspects of normal life for those suffering from ADHD.

She suggests that women who are unsure about whether to keep or stop medication in light of their pregnancy should consider informing family members, friends and colleagues about the condition, its impact on daily functioning, and on the benefits of keeping the current treatment regimen. It will also help a woman feel more confident in her decision. Certain medications can be passed through the placenta. If the patient decides not to take her ADHD medication while breastfeeding, it is important to be aware that the medication could be transferred to the baby.

Birth Defects and Risk of

As the use and use of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD), increases as does the concern about the possible effects of the drugs on fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of information on this topic. With two massive data sets, researchers were able to examine more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. While the overall risk remains low, the researchers found that exposure in the first trimester to ADHD medications was associated with an increase in the risk of certain heart defects such as ventriculoseptal defect (VSD).

The researchers of the study could not discover any connection between the use of early medications and congenital anomalies like facial deformities or club feet. The results are in line with previous studies revealing the presence of a small, but significant increase in the risk of cardiac malformations among women who began taking ADHD medications before the time of pregnancy. The risk grew in the later part of pregnancy, when many women decide to stop taking their ADHD medication.

Women who took ADHD medication in the first trimester of pregnancy were also more likely to undergo caesarean sections, a low Apgar score after delivery and a baby who needed breathing assistance during birth. However the authors of the study were not able to eliminate selection bias by limiting the study to women who didn't have any other medical issues that could have contributed to these findings.

The researchers hope that their research will help inform the clinical decisions of doctors who treat pregnant women. The researchers advise that, while discussing risks and benefits are important, the decision regarding whether or not to stop taking medication should be based on the severity of each woman's ADHD symptoms and her requirements.

The authors warn that, while stopping the medication is an option to think about, it isn't recommended due to the high prevalence of depression and other mental problems for women who are pregnant or have recently given birth. Further, research shows that women who stop taking their medications will have a difficult time adjusting to a life without them once the baby is born.

Nursing

It can be a challenge becoming a mother. Women who suffer from ADHD who have to manage their symptoms while attending physician appointments as well as making preparations for the arrival of their child and adapting to new routines in the home are often faced with a number of difficulties. Therefore, many women elect to continue taking their ADHD medications throughout pregnancy.

The majority of stimulant medicines are absorbed through breast milk in very small amounts, therefore the risk to the nursing infant is very low. However, the amount of exposure to medication by the newborn may differ based on the dosage, frequency it is administered, and the time of day the medication is administered. In addition, various drugs enter the infant's system via the gastrointestinal tract or breast milk. The impact on the health of a newborn isn't fully understood.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the absence of research. This is a difficult decision for the woman who must weigh the advantages of her medication against the risk to the embryo. In the meantime, until more information is available, doctors may inquire about pregnant patients if they have a background of ADHD or if they intend to take medication during the perinatal stage.

A increasing number of studies have revealed that most women can safely continue to take their ADHD medication during pregnancy and breastfeeding. In response, a growing number of patients are opting to do this. They have discovered after consulting with their physicians, that the benefits of retaining their current medication outweigh risk.

It is essential for women with ADHD who are thinking of breastfeeding to seek out a specialist psychiatrist's advice prior becoming pregnant. They should review their medications with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation is also necessary to help pregnant women suffering from ADHD be aware of the symptoms and underlying disorder. They should also learn about treatment options and reinforce the coping mechanisms. This should be a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Pregnancy counselling should include the discussion of a treatment plan for both mother and child, as well as monitoring for signs of deterioration and when necessary, making adjustments to the medication regimen.